Sino Biopharmaceutical Limited

ISIN KYG8167W1380 Symbol 1177 Industry Biotechnology Sector Healthcare
Sino Biopharmaceutical Price
7.70HKD 1.18%
1y Low: 6.5
1y High: 11.2
1y Low: 6.5
1y High: 11.2
sinobiopharm.com
Market Cap
19.9 B USD
Dividend Yield
0.8%
Performance 1y
24.00 %
PER
34.0

Sino Biopharmaceutical Stock Chart

Sino Biopharmaceutical Dividend Chart

Sino Biopharmaceutical Dividend Calendar

Year # Div. Div. Paid Div. Yield Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2021 1 0.020 HKD 0.7 %
2020 3 0.053 HKD 0.7 %
2019 3 0.040 HKD 0.6 %
2018 3 0.040 HKD 1.2 %
2017 4 0.031 HKD 0.6 %
2016 4 0.027 HKD 1.2 %
2015 4 0.018 HKD 0.6 %
2014 4 0.019 HKD 1.0 %
2013 4 0.015 HKD 0.9 %
2012 4 0.012 HKD 1.2 %
2011 4 0.024 HKD 3.8 %
2010 4 0.024 HKD 3.2 %
2009 4 0.012 HKD 2.1 %
2008 4 0.0089 HKD 6.7 %
2007 4 0.0089 HKD 5.0 %
2006 4 0.0067 HKD 6.0 %
2005 4 0.030 HKD 17.4 %
2004 3 0.024 HKD 24.9 %
2003 2 0.0034 HKD 7.3 %
2002 2 0.0037 HKD 7.8 %
2001 2 0.0022 HKD 4.7 %

Sino Biopharmaceutical Performance

1 Week
1 Month
17.13 %
6 Months
0.54 %
Year to Date
2.60 %
1 Year
24.00 %
5 Years
265.8 %

Sino Biopharmaceutical Revenue, EBIT, and Income

Sino Biopharmaceutical Margins

Sino Biopharmaceutical Shares Outstanding

Useful Links

Search Twitter: $1177, #1177

Sino Biopharmaceutical Company Info

Sino Biopharmaceutical Limited, together with its subsidiaries, operates as a research and development pharmaceutical conglomerate in the People's Republic of China. The company operates in three segments: Chinese Medicines, Investment, and Others. Its principal products include hepatitis medicines, such as Tianqingganmei injections and Tianqingganping enteric capsules; oncology medicines comprising Saiweijian injections, Yinishu tablets, Shoufu tablets, Anxian capsules, and Qianping injections; cardio-cerebral medicines, including Yilunping tablets, Tuotuo tablets, and Kaina tablets; and orthopedic medicines, such as Gaisanchun capsules and Yigu injections. The company's principal products also comprise digestive system medicines that consist of Aisuping injections, Getai tablets, and Deyou granules; anti-infectious medicines that include Tiance injections, Tianjie injections, and Tianli injections; respiratory system medicines, such as Tianqingsule inhalation powder; and others comprising Debaian cataplasms. In addition, it engages in property holding activities; the retail and distribution of pharmaceutical products; optometry for optical glasses and sale of ophthalmic products; the provision of medical management consultancy services; and outpatient and surgical procedure. Further, the company manufactures, sells, and distributes health food; and develops medical technology. Sino Biopharmaceutical Limited was incorporated in 2000 and is headquartered in Wan Chai, Hong Kong.

Sino Biopharmaceutical Headquarter

Office Tower, Wan Chai, Hong Kong

Sino Biopharmaceutical Price to Earnings Ratio (PE Ratio): 34.0

The current Price to Earnings Ratio of Sino Biopharmaceutical is 34.0.
The PE Ratio is calcluated by dividing the current Sino Biopharmaceutical share price (7.70 HKD) by the earnings per share (0.2).

Sino Biopharmaceutical Dividend Yield: 0.8%

The current Dividend Yield of Sino Biopharmaceutical is 0.8%.

Sino Biopharmaceutical Market Cap: 19.9 B USD

The current market cap of Sino Biopharmaceutical is 19.9 B USD.

Sino Biopharmaceutical Stock Price: 7.70 HKD

The current stock price of Sino Biopharmaceutical is 7.70 HKD (0.99 USD).

Sino Biopharmaceutical ISIN: KYG8167W1380

The ISIN (International Securities Identification Number) of Sino Biopharmaceutical is KYG8167W1380.

Sino Biopharmaceutical Ticker Symbol: 1177

The ticker symbol of Sino Biopharmaceutical is 1177.

Sino Biopharmaceutical Address

The address of the Sino Biopharmaceutical HQ is Office Tower, Wan Chai, Hong Kong.